Literature DB >> 26654973

Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization.

Lynn Sterling1, Jennifer Liu2, Nan Okun3, Anamika Sakhuja2, Sony Sierra4, Ellen Greenblatt5.   

Abstract

OBJECTIVE: To determine whether the diagnosis of polycystic ovary syndrome (PCOS) independently predicts increased rates of pregnancy complications relative to control subjects, after adjusting for important confounders.
DESIGN: Retrospective cohort.
SETTING: Not applicable. PATIENT(S): A review of all pregnancies after fresh IVF with or without intracytoplasmic sperm injection transfers from December 2006 to 2012 (n = 1,084) identified 394 eligible singleton births (71 women with PCOS; 323 controls without). INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Singleton births were assessed for selected adverse pregnancy and birth outcomes. RESULT(S): Women with PCOS demonstrated a higher risk of developing the following pregnancy complications after adjusting for differences in age, parity, body mass index, and time to conception: gestational diabetes (adjusted odds ratio [AOR] 3.15, 95% confidence interval [CI] 1.35-7.33), hypertensive disorders of pregnancy (AOR 4.25, 95% CI 1.94-9.32), preterm birth <37 weeks (AOR 2.30, 95% CI 1.07-4.97), and large for gestational age >90th percentile (AOR 2.77, 95% CI 1.21-6.35). The increased risk of preterm birth <37 weeks was eliminated after adjusting for development of hypertensive disorders of pregnancy, whereas the increased risk of large for gestational age remained significant after adjusting for gestational diabetes mellitus status. Time to conception did not differ significantly between groups, nor did rates of antepartum hemorrhage, cesarean section, or perinatal mortality. CONCLUSION(S): Polycystic ovary syndrome independently predicts higher risk of adverse pregnancy outcomes after adjusting for differences in maternal age, parity, body mass index, and time to conception. This new information may be of relevance in counseling and monitoring women with PCOS, although larger prospective studies may be needed to validate our findings.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes (gestational); hypertension (pregnancy-induced); in vitro fertilization; polycystic ovary syndrome; pregnancy outcomes

Mesh:

Year:  2015        PMID: 26654973     DOI: 10.1016/j.fertnstert.2015.11.019

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Chronic hyperandrogenemia and western-style diet beginning at puberty reduces fertility and increases metabolic dysfunction during pregnancy in young adult, female macaques.

Authors:  C V Bishop; R L Stouffer; D L Takahashi; E C Mishler; M C Wilcox; O D Slayden; C A True
Journal:  Hum Reprod       Date:  2018-04-01       Impact factor: 6.918

Review 2.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

Review 3.  Maternal cholesterol levels during gestation: boon or bane for the offspring?

Authors:  V S Jayalekshmi; Surya Ramachandran
Journal:  Mol Cell Biochem       Date:  2020-09-22       Impact factor: 3.396

Review 4.  Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis.

Authors:  Roberto Matorras; Jose Ignacio Pijoan; Lucía Laínz; María Díaz-Nuñez; Héctor Sainz; Silvia Pérez-Fernandez; Dayana Moreira
Journal:  Arch Gynecol Obstet       Date:  2022-09-04       Impact factor: 2.493

5.  Correlation Analysis of Vaspin Gene Polymorphisms and Polycystic Ovary Syndrome Based on Intelligent Medicine.

Authors:  Yingjie Tang; Ting Huang; Yingzheng Pan
Journal:  Comput Intell Neurosci       Date:  2022-05-16

6.  MicroRNA-141 and MicroRNA-200c Are Overexpressed in Granulosa Cells of Polycystic Ovary Syndrome Patients.

Authors:  Tingting He; Yuan Liu; Yueyue Jia; Haiyan Wang; Xiao Yang; Gang Lu; Hongbin Liu; Yuhua Shi
Journal:  Front Med (Lausanne)       Date:  2018-10-29

7.  Perinatal outcome of in vitro fertilization singletons - 10 years' experience of one center.

Authors:  Iwona Szymusik; Katarzyna Kosinska-Kaczynska; Maria Krowicka; Milena Sep; Piotr Marianowski; Miroslaw Wielgos
Journal:  Arch Med Sci       Date:  2019-01-30       Impact factor: 3.318

8.  Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome.

Authors:  Qing Xiao; Yong-Yi Cui; Jine Lu; Guo-Zheng Zhang; Fang-Ling Zeng
Journal:  Int J Endocrinol       Date:  2016-03-14       Impact factor: 3.257

9.  The relationship between ovarian endometriosis and clinical pregnancy and abortion rate based on logistic regression model.

Authors:  Xiaoliang Mo; Yachang Zeng
Journal:  Saudi J Biol Sci       Date:  2019-11-25       Impact factor: 4.219

10.  Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.

Authors:  Jialyu Huang; Qin Xie; Jiaying Lin; Xuefeng Lu; Jing Zhu; Hongyuan Gao; Renfei Cai; Yanping Kuang
Journal:  Drug Des Devel Ther       Date:  2019-12-31       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.